Literature DB >> 21317395

Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias.

Kenneth Lau1, Patrick Benitez, Alexandria Ardissone, Tenisha D Wilson, Erin L Collins, Graciela Lorca, Nan Li, Dhyana Sankar, Clive Wasserfall, Josef Neu, Mark A Atkinson, Desmond Shatz, Eric W Triplett, Joseph Larkin.   

Abstract

Although it is known that resident gut flora contribute to immune system function and homeostasis, their role in the progression of the autoimmune disease type 1 diabetes (T1D) is poorly understood. Comparison of stool samples isolated from Bio-Breeding rats, a classic model of T1D, shows that distinct bacterial populations reside in spontaneous Bio-Breeding diabetes-prone (BBDP) and Bio-Breeding diabetes-resistant animals. We have previously shown that the oral transfer of Lactobacillus johnsonii strain N6.2 (LjN6.2) from Bio-Breeding diabetes-resistant to BBDP rodents conferred T1D resistance to BBDP rodents, whereas Lactobacillus reuteri strain TD1 did not. In this study, we show that diabetes resistance in LjN6.2-fed BBDP rodents was correlated to a Th17 cell bias within the mesenteric lymph nodes. The Th17 bias was not observed in the non-gut-draining axillary lymph nodes, suggesting that the Th17 bias was because of immune system interactions with LjN6.2 within the mesenteric lymph node. LjN6.2 interactions with the immune system were observed in the spleens of diabetes-resistant, LjN6.2-fed BBDP rats, as they also possessed a Th17 bias in comparison with control or Lactobacillus reuteri strain TD1-fed rats. Using C57BL/6 mouse in vitro assays, we show that LjN6.2 directly mediated enhanced Th17 differentiation of lymphocytes in the presence of TCR stimulation, which required APCs. Finally, we show that footpad vaccination of NOD mice with LjN6.2-pulsed dendritic cells was sufficient to mediate a Th17 bias in vivo. Together, these data suggest an interesting paradigm whereby T1D induction can be circumvented by gut flora-mediated Th17 differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317395     DOI: 10.4049/jimmunol.1001864

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.

Authors:  Kirsty Brown; Artem Godovannyi; Caixia Ma; YiQun Zhang; Zahra Ahmadi-Vand; Chaunbin Dai; Monika A Gorzelak; YeeKwan Chan; Justin M Chan; Arion Lochner; Jan P Dutz; Bruce A Vallance; Deanna L Gibson
Journal:  ISME J       Date:  2015-08-14       Impact factor: 10.302

Review 2.  Type 1 diabetes and celiac disease: clinical overlap and new insights into disease pathogenesis.

Authors:  Aaron Cohn; Anthony M Sofia; Sonia S Kupfer
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

3.  Isolation and th17 differentiation of naïve CD4 T lymphocytes.

Authors:  Simone K Bedoya; Tenisha D Wilson; Erin L Collins; Kenneth Lau; Joseph Larkin
Journal:  J Vis Exp       Date:  2013-09-26       Impact factor: 1.355

Review 4.  The crucial role of early-life gut microbiota in the development of type 1 diabetes.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Xue Zhao; Xiaokun Gang; Guixia Wang
Journal:  Acta Diabetol       Date:  2020-07-25       Impact factor: 4.280

Review 5.  Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Authors:  Youjia Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2017-02-07       Impact factor: 7.658

6.  Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes.

Authors:  Aimon K Alkanani; Naoko Hara; Peter A Gottlieb; Diana Ir; Charles E Robertson; Brandie D Wagner; Daniel N Frank; Danny Zipris
Journal:  Diabetes       Date:  2015-06-11       Impact factor: 9.461

Review 7.  Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease.

Authors:  M A Atkinson; A Chervonsky
Journal:  Diabetologia       Date:  2012-08-09       Impact factor: 10.122

Review 8.  Gut microbiota and type 1 diabetes.

Authors:  Outi Vaarala
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 9.  The microbiota, the immune system and the allograft.

Authors:  M-L Alegre; R B Mannon; P J Mannon
Journal:  Am J Transplant       Date:  2014-05-19       Impact factor: 8.086

10.  Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice.

Authors:  Martin A Kriegel; Esen Sefik; Jonathan A Hill; Hsin-Jung Wu; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.